Search results
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5%
ETF DAILY NEWS· 1 day agoPhio Pharmaceuticals Corp. (NASDAQ:PHIO – Get Free Report) rose 2.5% during trading on Thursday . The company traded as high as $0.75 and last traded at $0.74. Approximately ...
Ori Gutwerg Sells 2,985 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock
ETF DAILY NEWS· 21 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) SVP Ori Gutwerg sold 2,985 shares of the stock in a transaction dated Wednesday, June 5th. The ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 12 hours agoIn terms of fundamental and technical metrics, the best biotech stocks trading above 10 right now...
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
InvestorPlace· 19 hours agoIn a meme frenzy, any positive news related to a company has a magnified impact on the stock price. ...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 1 day agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Down to $244.35
ETF DAILY NEWS· 24 hours agoMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report)’s stock price gapped down prior to trading on Wednesday . Madrigal < ...
Halozyme Therapeutics Scores RS Rating Jump To 91
Investor's Business Daily· 12 hours agoOn Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91. See if the biotech stock
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 18 hours agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
June's Biotech Boom: 3 Stocks to Buy for a Summertime Surge
InvestorPlace· 3 days agoBiotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the...
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
The Motley Fool via AOL· 20 hours agoAll of this means that, if you're a Lilly investor, the next time you hear about a biotech company...